Skip to main content

Table 1 Perioperative cardiopulmonary hemodynamics

From: Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report

  mPAP (mmHg) PCWP (mmHg) CO (L/min) TR-PPG (mmHg) PVR (dynes s/cm5) Tadalafil (mg/day) PGE1 (ng/kg/min)
Pretransplant (42 days before Tx) 54 NA NA 62.2 520 0 0
Pretransplant (1 month before Tx) 35 9 4.20 NA 476 0 0
Pretransplant (7 days before Tx) 22 NA NA 26.3 184 20 0
On laparotomy 29 NA 6.9 NA NA 0 0
On anhepatic phase 23 NA NA NA NA 0 0
Immediately after reperfusion 45 NA NA NA NA 0 0
At the end of surgery 30 NA 7.7 NA NA 0 7
POD1 27 NA 8.0 NA NA 0 7
POD2 (before withdrawal of PGE1) 22 NA 6.8 NA NA 0 7
POD2 (after withdrawal of PGE1) 23 NA 5.8 NA NA 0 0
POD60 24 NA NA 28.3 234 0 0
POD62 22 8 4.56 NA 266 0 0
  1. mPAP mean pulmonary artery pressure, PCWP pulmonary capillary wedge pressure, CO cardiac output, TR-PPG TR-peak pressure gradient, PVR pulmonary vascular resistance, NA not applicable, POD postoperative day
  2. Values were estimated by echocardiography